ExCulture has secured €350,000 from UNIIQ/Delft Enterprises. This substantial funding, combined with the support of UNIIQ will propel ExCulture further on our mission to develop an animal-free, alternative heparin. We are grateful to have the opportunity to contribute to the innovation ecosystem of Zuid Holland.
For more information check out the UNIIQ press release here.
